Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ALAN MATARASSO

Allopathic & Osteopathic Physicians Plastic Surgery

NPI
1639222524
CMS profile
1064559
Location
NEW YORK, NY

General Payments · PY2018–2024

$36,662.42

  • Reported across 42 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$7,947.25

12 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $6,500.00 1
Travel and Lodging $1,215.05 6
Food and Beverage $232.20 5

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
VERTEX PHARMACEUTICALS INCORPORATED $7,947.25 12

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $3,552.35 12
PY2019 $35.16 2
PY2020 $16,541.30 12
PY2021 $8,250.00 1
PY2022 $225.83 2
PY2023 $110.53 1
PY2024 $7,947.25 12

Payment records · PY2024 (12)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
VERTEX PHARMACEUTICALS INCORPORATED $649.35 11/15/2024 Travel and Lodging Undisputed 01/23/2026 1105909036 CMS
VERTEX PHARMACEUTICALS INCORPORATED $34.30 11/16/2024 Food and Beverage Undisputed 01/23/2026 1105904226 CMS
VERTEX PHARMACEUTICALS INCORPORATED $81.43 11/16/2024 Travel and Lodging Undisputed 01/23/2026 1105907663 CMS
VERTEX PHARMACEUTICALS INCORPORATED $20.26 11/16/2024 Food and Beverage Undisputed 01/23/2026 1105913910 CMS
VERTEX PHARMACEUTICALS INCORPORATED $22.73 11/16/2024 Food and Beverage Undisputed 01/23/2026 1105918020 CMS
VERTEX PHARMACEUTICALS INCORPORATED $336.55 11/16/2024 Travel and Lodging Undisputed 01/23/2026 1105924263 CMS
VERTEX PHARMACEUTICALS INCORPORATED $61.44 12/11/2024 Travel and Lodging Undisputed 01/23/2026 1105903563 CMS
VERTEX PHARMACEUTICALS INCORPORATED $61.82 12/11/2024 Food and Beverage Undisputed 01/23/2026 1105912558 CMS
VERTEX PHARMACEUTICALS INCORPORATED $25.75 12/11/2024 Travel and Lodging Undisputed 01/23/2026 1105917350 CMS
VERTEX PHARMACEUTICALS INCORPORATED $93.09 12/11/2024 Food and Beverage Undisputed 01/23/2026 1105918740 CMS
VERTEX PHARMACEUTICALS INCORPORATED $6,500.00 12/11/2024 Consulting Fee Undisputed 01/23/2026 1105920787 CMS
VERTEX PHARMACEUTICALS INCORPORATED $60.53 12/11/2024 Travel and Lodging Undisputed 01/23/2026 1105922881 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.